Breathe: 17 (4)

01 December 2021; volume 17, issue 4

Editorials

Open Access
Targeted therapy in respiratory disease
Brian D. Kent

Breathe Dec 2021, 17 (4) 210170; DOI: 10.1183/20734735.0170-2021
Open Access
The COVID-19 surge in Indonesia: what we learned and what to expect
Eric Daniel Tenda, Moses Mazmur Asaf, Ariel Pradipta, Meutia Ayuputeri Kumaheri, Anindya Pradipta Susanto

Breathe Dec 2021, 17 (4) 210146; DOI: 10.1183/20734735.0146-2021

Patient voice

Open Access
Patient experiences of biologic treatment for severe asthma: the good, the outstanding and the deeply frustrating
Jessica Denning, Jenny Negus, Niamh Cullen

Breathe Dec 2021, 17 (4) 210145; DOI: 10.1183/20734735.0145-2021

Viewpoint

Open Access
Palivizumab immunoprophylaxis for infants with BPD has medium- and long-term benefits: myth or maxim?
Lauren A. Quinn, Sunaya H. Hirani, Thomas C. Williams, Ian P. Sinha

Breathe Dec 2021, 17 (4) 210110; DOI: 10.1183/20734735.0110-2021

Reviews

Open Access
A pragmatic guide to choosing biologic therapies in severe asthma
Joanne E. Kavanagh, Andrew P. Hearn, David J. Jackson

Breathe Dec 2021, 17 (4) 210144; DOI: 10.1183/20734735.0144-2021
Open Access
Progress in precision medicine in cystic fibrosis: a focus on CFTR modulator therapy
Daniel H. Tewkesbury, Rebecca C. Robey, Peter J. Barry

Breathe Dec 2021, 17 (4) 210112; DOI: 10.1183/20734735.0112-2021
Open Access
The use of treatable traits to address COPD complexity and heterogeneity and to inform the care
Katarzyna Duszyk, Rebecca F. McLoughlin, Peter G. Gibson, Vanessa M. McDonald

Breathe Dec 2021, 17 (4) 210118; DOI: 10.1183/20734735.0118-2021
Open Access
Stating the obvious: intravenous magnesium sulphate should be the first parenteral bronchodilator in paediatric asthma exacerbations unresponsive to first-line therapy
Gokul Erumbala, Sabu Anzar, Amjad Tonbari, Ramadan Salem, Colin Powell

Breathe Dec 2021, 17 (4) 210113; DOI: 10.1183/20734735.0113-2021
Open Access
Precision medicine in bronchiectasis
Thomas Pembridge, James D. Chalmers

Breathe Dec 2021, 17 (4) 210119; DOI: 10.1183/20734735.0119-2021

Expert opinion

Case report
- Open Access
  In pursuit of the primary
  Jane Mendonca, Vishak Acharya, Sanyo D'souza, Kausalya Kumari Sahu, Sindhu Kamath, Jyoti R. Kini
  
  Breathe Dec 2021, 17 (4) 210142; DOI: 10.1183/20734735.0142-2021
- Open Access
  A young man with transitory hemiparesis and lung infiltrates
  Anja Ljilja, Niko Radović, Jasna Tekavec-Trkanjec
  
  Breathe Dec 2021, 17 (4) 210069; DOI: 10.1183/20734735.0069-2021
- Open Access
  First report of a very rare complication in a case of nonsmall cell lung carcinoma
  Inês Moreira, Ana Sofia Vilariça, Paula Alves
  
  Breathe Dec 2021, 17 (4) 210107; DOI: 10.1183/20734735.0107-2021
- Open Access
  A case of haemoptysis and bilateral areas of lung consolidation sparing the right lower lobe
  Nadia Corcione, Antonio Ponticiello, Severo Campione, Alfonso Pecoraro, Livio Moccia, Giuseppe Failla
  
  Breathe Dec 2021, 17 (4) 210072; DOI: 10.1183/20734735.0072-2021
- Open Access
  Syncope: a complication of chronic cough
  Jenny King, Sarah Hennessey, James Wingfield Digby, Jaclyn Ann Smith, Paul Marsden
  
  Breathe Dec 2021, 17 (4) 210094; DOI: 10.1183/20734735.0094-2021
Early career forum
- Open Access
  ERS ECM Awardee 2021, a preview of LSC 2022 and a brief overview of the Respiratory Channel
  João C. Costa, Philip Mitchelmore, Niki D. Ubags, Cristina Calarasu, Holly R. Keir, Joana Cruz
  
  Breathe Dec 2021, 17 (4) 210121; DOI: 10.1183/20734735.0121-2021
Doing science
- Open Access
  Contribution of causal factors to disease burden: how to interpret attributable fractions
  Emilie Counil
  
  Breathe Dec 2021, 17 (4) 210086; DOI: 10.1183/20734735.0086-2021
Journal club
- Open Access
  Lung cancer screening by volume computed tomography: thriving to high performance
  Eline Schillebeeckx, Kevin Lamote
  
  Breathe Dec 2021, 17 (4) 210063; DOI: 10.1183/20734735.0063-2021
- Open Access
  Is the GOLD guideline for diagnosing obstruction in COPD discriminatory in predicting severe future COPD-related exacerbations and death?
  Melissa J. McDonnell, Michael Harrison, Robert M. Rutherford
  
  Breathe Dec 2021, 17 (4) 210046; DOI: 10.1183/20734735.0046-2021
Ask the expert
- Open Access
  Choosing pharmacotherapy for ILD in patients with connective tissue disease
  Zhe Wu, Philip L. Molyneaux
  
  Breathe Dec 2021, 17 (4) 210114; DOI: 10.1183/20734735.0114-2021

Acknowledgement

Open Access
Breathe, list of peer reviewers 2021
Breathe Dec 2021, 17 (4) 211741; DOI: 10.1183/20734735.1741-2021

Main menu

User menu

Search

Table of Contents

Editorials

Patient voice

Viewpoint

Reviews

Expert opinion

Case report

Early career forum

Doing science

Journal club

Ask the expert

Acknowledgement

Search Within This Issue

Jump to

Contact us